Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Discrete scattering by a pair of parallel defects.

Sharma BL, Maurya G.

Philos Trans A Math Phys Eng Sci. 2020 Jan 10;378(2162):20190102. doi: 10.1098/rsta.2019.0102. Epub 2019 Nov 25.

PMID:
31760901
2.

A community-based knowledge, attitude, and practice survey on rabies among cattle owners in selected areas of Bhutan.

Rinchen S, Tenzin T, Hall D, van der Meer F, Sharma B, Dukpa K, Cork S.

PLoS Negl Trop Dis. 2019 Apr 1;13(4):e0007305. doi: 10.1371/journal.pntd.0007305. eCollection 2019 Apr.

3.

Beneficial Effect of Silymarin in Pressure Overload Induced Experimental Cardiac Hypertrophy.

Sharma B, Chaube U, Patel BM.

Cardiovasc Toxicol. 2019 Feb;19(1):23-35. doi: 10.1007/s12012-018-9470-2.

PMID:
29968071
4.

Lung disease associated with occupational styrene exposure.

Meyer KC, Sharma B, Kaufmann B, Kupper A, Hodgson M.

Am J Ind Med. 2018 Jun 13. doi: 10.1002/ajim.22867. [Epub ahead of print]

PMID:
29900554
5.

Revisiting an old disease? Risk factors for bovine enzootic haematuria in the Kingdom of Bhutan.

Hidano A, Sharma B, Rinzin K, Dahal N, Dukpa K, Stevenson MA.

Prev Vet Med. 2017 May 1;140:10-18. doi: 10.1016/j.prevetmed.2017.02.011.

PMID:
28460742
6.

A cross-sectional survey of population demographics, the prevalence of major disease conditions and reason-specific proportional mortality of domestic cattle in the Kingdom of Bhutan.

Hidano A, Dukpa K, Rinzin K, Sharma B, Dahal N, Stevenson MA.

Prev Vet Med. 2016 Aug 1;130:1-9. doi: 10.1016/j.prevetmed.2016.05.012. Epub 2016 May 25.

PMID:
27435641
7.

Reemergence of rabies in Chhukha district, Bhutan, 2008.

Tenzin, Sharma B, Dhand NK, Timsina N, Ward MP.

Emerg Infect Dis. 2010 Dec;16(12):1925-30. doi: 10.3201/eid1612.100958.

8.

Immunogenicity of therapeutic proteins. Part 2: impact of container closures.

Sharma B.

Biotechnol Adv. 2007 May-Jun;25(3):318-24. Epub 2007 Jan 30. Review.

PMID:
17337336
9.

Immunogenicity of therapeutic proteins. Part 3: impact of manufacturing changes.

Sharma B.

Biotechnol Adv. 2007 May-Jun;25(3):325-31. Epub 2007 Jan 30. Review.

PMID:
17337334
10.

Immunogenicity of therapeutic proteins. Part 1: impact of product handling.

Sharma B.

Biotechnol Adv. 2007 May-Jun;25(3):310-7. Epub 2007 Jan 30. Review.

PMID:
17336479
11.

A modified posterior approach for upper eyelid retraction.

Looi AL, Sharma B, Dolman PJ.

Ophthalmic Plast Reconstr Surg. 2006 Nov-Dec;22(6):434-7.

PMID:
17117096
12.

Reactions to Eprex's adverse reactions.

Sharma B, Ryan MH, Boven K.

Nat Biotechnol. 2006 Oct;24(10):1199-200; author reply 1200. No abstract available.

PMID:
17033648
13.
14.

An in vivo model to assess factors that may stimulate the generation of an immune reaction to erythropoietin.

Ryan MH, Heavner GA, Brigham-Burke M, McMahon F, Shanahan MF, Gunturi SR, Sharma B, Farrell FX.

Int Immunopharmacol. 2006 Apr;6(4):647-55. Epub 2005 Nov 14.

PMID:
16504928

Supplemental Content

Loading ...
Support Center